GlassScriptPhysician profile
Sanjeev Kakar
NPI 1891960290
$2,071,062.28
in general payments reported to CMS, 2019-2025
28 companies · $652K in 2025
The $652K reported for 2025 was more than what 99% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171K · 2020: $165K · 2021: $177K · 2022: $288K · 2023: $317K · 2024: $302K · 2025: $652K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $956K · Consulting Fee: $139K · Travel and Lodging: $100K · Royalty Or License: $71K · Food and Beverage: $5,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $956,007.69 |
| Consulting Fee | $139,388.33 |
| Travel and Lodging | $100,025.07 |
| Royalty Or License | $70,670.97 |
| Food and Beverage | $5,033.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,054,520.95 | 2019-2025 | Arthrex, Distal Extremities Implants Soft Tissue H&W Mini Tightropes, Distal Extremities Implants Soft Tissue Anchors |
| Restor3d, INC. | $6,799.60 | 2021-2022 | |
| Akcea Therapeutics, INC. | $3,500.00 | 2020 | |
| Endo Pharmaceuticals INC. | $3,025.02 | 2019-2021 | |
| Gemini Medical LLC | $469.93 | 2019-2021 | |
| Foundation Medical, LLC | $404.33 | 2023-2025 | |
| Medwest Associates | $323.74 | 2019-2022 | |
| Acumed LLC | $268.22 | 2019 | |
| Medartis INC. | $221.34 | 2024-2025 | Aptus |
| Kairos Surgical INC | $175.20 | 2022-2024 | |
| Trimed, INC. | $163.53 | 2025 | |
| Axogen | $143.05 | 2025 | |
| Zimmer Biomet Holdings, INC. | $128.54 | 2023 | A.L.P.S. |
| Pylant Medical | $123.04 | 2022 | |
| Checkpoint Surgical, INC | $122.99 | 2025 | Checkpoint Stimulators |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $120.96 | 2024 | |
| Smith+Nephew, INC. | $116.28 | 2025 | Integra |
| Kls-Martin L.P. | $108.14 | 2022 | |
| Medinc of Texas | $89.39 | 2023 | |
| Great Lakes Orthopedics | $54.24 | 2020 | |
| Elevate Surgical Co | $37.28 | 2025 | |
| United Orthopedics LLC | $33.74 | 2024 | |
| Conetic Solutions, INC. | $28.27 | 2025 | |
| Cosa Medical, LLC | $24.61 | 2025 | |
| Peerless Surgical INC. | $23.17 | 2024 | |
| Summit Surgical Corp. | $23.04 | 2021 | |
| Orthofix Medical, INC. | $13.68 | 2025 | Physio-Stim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,746.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Kakar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.